One to two months after the completion of WT1-DC treatment, the size of the cancers was assessed by CT and MRI scans, and all patients in the lung cancer group had PR, while two patients in the pancreatic cancer group had SD, and one patient had PD. At the time of writing this paper, there were no deaths in the lung cancer group, but in the pancreatic cancer group, all died due to exacerbation of pancreatic cancer (Figure 1). This evidence concerns the gene WT1 and lung cancer.